|

zorifertinib Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Alpha Biopharma (Jiangsu) Co., Ltd.1

Indications

  • Central Nervous System (CNS) Metastases1
  • EGFR Mutant Advanced Non-Small Cell Lung Cancer1
  • Lung Cancer1
  • Cancer1

Other1 trial

A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.